Vanda Pharmaceuticals VNDA
NASDAQ VNDA
$4.84 -0.07 (-1.53%)
As of: Oct 1, 2026 · 11:34 AM EDT

Vanda Pharmaceuticals (VNDA) Receivables - Other (2011 - 2012)

Updated

Vanda Pharmaceuticals (VNDA) recorded Receivables - Other of $21,000 in Q3 2012, down 19.2% from the prior quarter.

Analysis

Vanda Pharmaceuticals (VNDA) Receivables - Other (2011 - 2012) Analysis & Trends

At the end of FY2011, Vanda Pharmaceuticals reported Receivables - Other of $116,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Vanda Pharmaceuticals 296.83 Mn -633.11 Mn 46.97 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2012 21,000.00
Jun 30, 2012 26,000.00
Dec 31, 2011 116,000.00
API Access

Vanda Pharmaceuticals Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=VNDA&period=max&api_key=YOUR_API_KEY